GAGE12H was found to be strongly upregulated in our system; however, TCGA data show that throughout the tumor samples, there are only a few which display a strong upregulation of GAGE12H across all cancer types, indicating random or patient-dependent alterations. Here, GAGE12H is linked to neoplasm.